Zobrazeno 1 - 9
of 9
pro vyhledávání: '"LDL/deficiency"'
Autor:
de Jong, Laura M, Zhang, Zhengzheng, den Hartog, Yvette, Sijsenaar, Timothy J P, Martins Cardoso, Renata, Manson, Martijn L, Hankemeier, Thomas, Lindenburg, Peter W, Salvatori, Daniela C F, Van Eck, Miranda, Hoekstra, Menno, Anatomie en fysiologie, CS_Locomotion, CS_Cancer
Publikováno v:
Scientific Reports, 12(1)
Scientific Reports, 12(1), 1. NLM (Medline)
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Scientific Reports
Scientific Reports, 12(1), 1. NLM (Medline)
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Scientific Reports
Protein arginine methyltransferase 3 (PRMT3) is a co-activator of liver X receptor capable of selectively modulating hepatic triglyceride synthesis. Here we investigated whether pharmacological PRMT3 inhibition can diminish the hepatic steatosis exte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ff1a6ab8a8e2e1f41477b08f243f05
http://hdl.handle.net/1887/3279356
http://hdl.handle.net/1887/3279356
Autor:
Shizuya Yamashita, M. Mahmood Hussain, Daniel J. Rader, Jahangir Iqbal, Marit Westerterp, Masahiro Koseki, Jay H. Lefkowitch, Alan R. Tall, Joanne Hsieh, Ikuyo Ichi, Robin B. Chan, Liana Tascau, Matthew M. Molusky, Carrie L. Welch, Sandra Abramowicz, Shunichi Takiguchi, Emi Yakushiji, Gilbert Di Paolo
Publikováno v:
Nature
Nature, 535:7611, 303-307. Nature Publishing Group
Nature, 535:7611, 303-307. Nature Publishing Group
Cellular mechanisms that mediate steatohepatitis, an increasingly prevalent condition in the Western world for which no therapies are available, are poorly understood. Despite the fact that its synthetic agonists induce fatty liver, the liver X recep
Autor:
Andrew J. Murphy, Marit Westerterp, Ira Tabas, Ayelet Gonen, Joseph L. Witztum, Manikandan Subramanian, Alan R. Tall, Mi Wang, Carrie L. Welch, Sandra Abramowicz
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology, 34(5), 976-984. Lippincott Williams and Wilkins
Arteriosclerosis, thrombosis, and vascular biology, 34(5), 976-984. LIPPINCOTT WILLIAMS & WILKINS
Arteriosclerosis, thrombosis, and vascular biology, 34(5), 976-984. LIPPINCOTT WILLIAMS & WILKINS
Objective— Coronary heart disease is associated with monocytosis. Studies using animal models of monocytosis and atherosclerosis such as ApoE −/− mice have shown bone marrow (BM) hematopoietic stem and multipotential progenitor cell (HSPC) expa
Publikováno v:
Cell reports. 13(1):132-144
Enhanced glucose utilization can be visualized in atherosclerotic lesions and may reflect a high glycolytic rate in lesional macrophages, but its causative role in plaque progression remains unclear. We observe that the activity of the carbohydrate-r
Autor:
Qizhi Wang, Chien-Ping Liang, Alan R. Tall, Marit Westerterp, Michihiro Matsumoto, Domenico Accili, Carrie L. Welch, Takafumi Senokuchi, Seongah Han
Publikováno v:
The Journal of Clinical Investigation, 119(4), 1029-1041. AMER SOC CLINICAL INVESTIGATION INC
Type 2 diabetes is associated with accelerated atherogenesis, which may result from a combination of factors, including dyslipidemia characterized by increased VLDL secretion, and insulin resistance. To assess the hypothesis that both hepatic and per
Autor:
Andrew J. Murphy, Vusisizwe Ntonga, Mojdeh S. Kappus, Sandra Abramowicz, Alan R. Tall, Marit Westerterp, Carrie L. Welch
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology, 34(2), 279-284. LIPPINCOTT WILLIAMS & WILKINS
Arteriosclerosis, thrombosis, and vascular biology, 34(2), 279-284. Lippincott Williams and Wilkins
Arteriosclerosis, thrombosis, and vascular biology, 34(2), 279-284. Lippincott Williams and Wilkins
Objective— Liver X receptor (LXR) activators decrease atherosclerosis in mice. LXR activators (1) directly upregulate genes involved in reverse cholesterol transport and (2) exert anti-inflammatory effects mediated by transrepression of nuclear fac
Autor:
Sarrazy, Vincent, Sore, Sophie, Viaud, Manon, Rignol, Guylène, Westerterp, Marit, Ceppo, Franck, Tanti, Jean-François, Guinamard, Rodolphe r., Gautier, Emmanuel L., Yvan-Charvet, Laurent
Publikováno v:
Cell Reports
Cell Reports, 2015, 13 (1), pp.132-144. ⟨10.1016/j.celrep.2015.08.068⟩
Cell Reports, Elsevier Inc, 2015, 13 (1), pp.132-144. ⟨10.1016/j.celrep.2015.08.068⟩
Cell reports, 13(1), 132-144. CELL PRESS
Cell Reports, Vol 13, Iss 1, Pp 132-144 (2015)
Cell Reports, 2015, 13 (1), pp.132-144. ⟨10.1016/j.celrep.2015.08.068⟩
Cell Reports, Elsevier Inc, 2015, 13 (1), pp.132-144. ⟨10.1016/j.celrep.2015.08.068⟩
Cell reports, 13(1), 132-144. CELL PRESS
Cell Reports, Vol 13, Iss 1, Pp 132-144 (2015)
International audience; Enhanced glucose utilization can be visualized in atherosclerotic lesions and may reflect a high glycolytic rate in lesional macrophages, but its causative role in plaque progression remains unclear. We observe that the activi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::035a43cfb378cad593dae2af5c8ac7d3
https://hal.science/hal-03798234
https://hal.science/hal-03798234
Autor:
Geindre, Sylvie Françoise, Kwak, Brenda, Pelli, Graziano, Roth, Isabelle, Satta Poschung, Nathalie, Fish, Richard, Reber, Guido, Mach, François, Kruithof, Egbert, De Moerloose, Philippe
Publikováno v:
Thrombosis and Haemostasis, Vol. 97, No 1 (2007) pp. 129-38
Antiphospholipid antibodies are a risk factor for venous and arterial thrombosis and may contribute to the development of atherosclerosis.The aim of this study was to investigate whether antibodies to human beta2-glycoprotein 1 (beta2GP1), as a model
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.